In a research report published Friday, H.C.
William Blair analyst John Sonnier maintained an Outperform rating on Agenus (NASDAQ:AGEN), as its partner GlaxoSmithKline (NYSE:GSK) reported positive Phase III results with an investigational …
In a research report sent to investors today, MLV analyst George Zavoico reiterated a Buy rating on Agenus (NASDAQ:AGEN) with a $6.00 price …
In a research report released today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Agenus (NASDAQ:AGEN) with a price target of $9.00, …
In a research report issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Agenus (NASDAQ:AGEN) with a $9 price target, which represents …
In a research report issued this morning, H.C.
In a research note released Tuesday, H.C.
In a research note issued this morning, H.C.
In a research note issued today, Maxim Group analyst Jason Kolbert reaffirmed a Buy rating on Agenus Inc. (AGEN) and a price target of $11, after AGEN announced the final data set …
